Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Molecular and biological characterization of a novel genetic disorder of the NF-kB pathway in Cree First Nations

EF 2016-17

Résumé
Up to 80,000 Albertans have a rare disease. With the greatest prevalence in children, such diseases dramatically impact the lives of both those suffering, and the families who care for them. Several of these immune diseases are caused by an impaired nuclear factor kB (NF-kB) pathway, through mutations in the NEMO and related proteins and have high morbidity and mortality. Patients with such mutations have a complex phenotype characterized by immune, skin, and bone abnormalities. Our work has identified a homozygous mutation in the TRAF6 gene, as the proposed novel cause of a life-threatening immunodeficiency disease.TRAF6 is a component of the NF-kB pathway required for NEMO activation, and homozygous mutations in this gene have not been previously associated with disease in humans. Characterized by multisystem organ involvement, this rare disease affects a child of Cree descent born to consanguineous parents from Alberta. The pathogenicity of the identified mutation is supported by in silico analysis, segregation in the family, and preliminary functional studies. The objective of this project is to test that the variant found in the patient is indeed the cause of her immunodeficiency. This will be achieved by analyzing the effect of the mutation on protein structure, the NF-kB pathway activity in a cell culture model, and the rescue of any observed defects using CRISPR technology. We are describing a novel genetic disease in a family of Cree descent, and propose a molecular basis for the disorder involving a gene not previously known to cause human disease. Our results aim to provide the family with personalized genetic counselling and might impact community at large, as well as contribute insights into a fundamental biological pathway.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367209
Name
Lewis Allison C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Molecular and biological characterization of a novel genetic disorder of the NF-kB pathway in Cree First Nations
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Canadian First Nations; Cell Signalling; Crispr; Immunodeficiency; New Genetic Disorder; Nuclear Factor Kappa B; Phosphorylation; Protein Structure; Protein-Protein Interaction; Ubiquitination
Abstract
Up to 80,000 Albertans have a rare disease. With the greatest prevalence in children, such diseases dramatically impact the lives of both those suffering, and the families who care for them. Several of these immune diseases are caused by an impaired nuclear factor kB (NF-kB) pathway, through mutations in the NEMO and related proteins and have high morbidity and mortality. Patients with such mutations have a complex phenotype characterized by immune, skin, and bone abnormalities. Our work has identified a homozygous mutation in the TRAF6 gene, as the proposed novel cause of a life-threatening immunodeficiency disease.TRAF6 is a component of the NF-kB pathway required for NEMO activation, and homozygous mutations in this gene have not been previously associated with disease in humans. Characterized by multisystem organ involvement, this rare disease affects a child of Cree descent born to consanguineous parents from Alberta. The pathogenicity of the identified mutation is supported by in silico analysis, segregation in the family, and preliminary functional studies. The objective of this project is to test that the variant found in the patient is indeed the cause of her immunodeficiency. This will be achieved by analyzing the effect of the mutation on protein structure, the NF-kB pathway activity in a cell culture model, and the rescue of any observed defects using CRISPR technology. We are describing a novel genetic disease in a family of Cree descent, and propose a molecular basis for the disorder involving a gene not previously known to cause human disease. Our results aim to provide the family with personalized genetic counselling and might impact community at large, as well as contribute insights into a fundamental biological pathway.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lewis, Allison C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~